GHRL and inflammatory bowel disease: We and others have shown that ghrelin ameliorates ischemia/reperfusion injury to the gut, sepsis enteropathy, duodenal ulcers, and preclinical models of inflammatory bowel disease (Wu et al. 2008; Li et al. 2019; Ceranowicz et al. 2009; Muthyala et al. 2022).